" and ZnBr non-flow."
And that goes some way to explaining your attitude to a company developing ZnBr flow, to which I have responded.
Seriously, there will be space and need for all types of solutions.
Plenty of room for all comers who have a product their markets want, who run a sound business model and continue developing their product.
- Forums
- ASX - By Stock
- RFX
- Ann: RFX FY2022 Results Presentation
Ann: RFX FY2022 Results Presentation, page-19
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.63M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RFX (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online